A detailed history of Signature Wealth Management Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Signature Wealth Management Group holds 70,703 shares of BMY stock, worth $3.44 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
70,703
Holding current value
$3.44 Million
% of portfolio
1.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$40.25 - $52.99 $2.85 Million - $3.75 Million
70,703 New
70,703 $2.94 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $29,256 - $37,938
-600 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$55.19 - $62.25 $607 - $684
-11 Reduced 1.8%
600 $30,000
Q1 2018

Apr 12, 2018

BUY
$59.92 - $68.98 $659 - $758
11 Added 1.83%
611 $39,000
Q4 2017

Apr 11, 2018

BUY
$59.94 - $65.35 $35,964 - $39,210
600
600 $37,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Signature Wealth Management Group Portfolio

Follow Signature Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Signature Wealth Management Group with notifications on news.